Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
1.510
+0.040 (2.72%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $29.42 million as of April 24, 2025. Its market cap has decreased by -75.93% in one year.
Market Cap
29.42M
Enterprise Value
18.87M
1-Year Change
-75.93%
Ranking
Category
Stock Price
$1.51
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has decreased from $62.51M to $29.42M, a decrease of -52.93%. That is a compound annual growth rate of -13.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2025 | 28.64M | -58.73% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | 51.96M | -16.87% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 744.81B |
| UnitedHealth Group | 389.54B |
| Johnson & Johnson | 374.44B |
| AbbVie | 313.20B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 225.18B |
| AstraZeneca | 213.42B |
| Novartis AG | 208.99B |